Hudson Bay Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Hudson Bay Capital Management’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-235,000	Closed	-$102K	–	1152
2022 Q4	$102K	Sell	235,000 -1,445,536	-86%	-$469K	﹤0.01%	760
2022 Q3	$471K	Hold	1,680,536	–	–	﹤0.01%	901
2022 Q2	$605K	Sell	1,680,536 -1,464	-0.1%	-$606	﹤0.01%	972
2022 Q1	$1.13M	Sell	1,682,000 -118,000	-7%	-$100K	0.02%	802
2021 Q4	$2.32M	Buy	1,800,000 +195,000	+12%	+$346K	0.02%	641
2021 Q3	$3.48M	Buy	1,605,000 +65,000	+4%	+$141K	0.05%	477
2021 Q2	$4.2M	Sell	1,540,000 -60,000	-4%	-$149K	0.05%	405
2021 Q1	$4.18M	Hold	1,600,000	–	–	0.05%	347
2020 Q4	$4.45M	Buy	1,600,000 +275,000	+21%	+$801K	0.05%	253
2020 Q3	$6.12M	Sell	1,325,000 -350,000	-21%	-$1.16M	0.09%	197
2020 Q2	$4.72M	Buy	1,675,000 +325,000	+24%	+$1.04M	0.08%	202
2020 Q1	$3.29M	Buy	1,350,000 +756,784	+128%	+$2.73M	0.08%	203
2019 Q4	$3.04M	Buy	593,216 +98,216	+20%	+$545K	0.07%	236
2019 Q3	$3.2M	Sell	495,000 -55,000	-10%	-$379K	0.09%	207
2019 Q2	$3.43M	Buy	550,000 +384,375	+232%	+$2.93M	0.08%	221
2019 Q1	$1.76M	Buy	165,625 +9,375	+6%	+$93.4K	0.02%	488
2018 Q4	$1.25M	Buy	156,250 +30,000	+24%	+$433K	0.02%	598
2018 Q3	$2.44M	Buy	126,250 +29,762	+31%	+$542K	0.03%	420
2018 Q2	$1.74M	Buy	96,488 +24,613	+34%	+$363K	0.02%	542
2018 Q1	$765K	Buy	71,875 +28,125	+64%	+$452K	0.02%	625
2017 Q4	$1.84M	Buy	+43,750	New	+$1.96M	0.04%	330
2017 Q2	–	Sell	-3,125	Closed	-$374K	–	856
2017 Q1	$374K	Buy	+3,125	New	+$328K	0.01%	724
2015 Q3	–	Sell	-2,500	Closed	-$408K	–	268
2015 Q2	$408K	Buy	+2,500	New	+$424K	0.01%	208

Other funds holding SIOX

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

CIA

Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Hudson Bay Capital Management's SIOX Position: Q1 2023 in Review

Hudson Bay Capital Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 235,000 shares — an estimated $102K sold.

Hudson Bay Capital Management first reported a position in SIOX in Q2 2015 and held it in 23 quarters. The position peaked at $6.12M in Q3 2020. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

Hudson Bay Capital Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 235,000 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $102K.
Hudson Bay Capital Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 23 quarters.
Hudson Bay Capital Management's Sio Gene Therapies Inc. Common Stock position peaked at $6.12M in Q3 2020.
4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Hudson Bay Capital Management's 13F filing for Q1 2023, filed 15 May 2023.